Israel -
hebreo -
Ministry of Health
אוורולימוס תרו 10 מג
taro international ltd, israel - everolimus - טבליה - everolimus 10 mg - everolimus
Israel -
hebreo -
Ministry of Health
אוורולימוס תרו 2.5 מג
taro international ltd, israel - everolimus - טבליה - everolimus 2.5 mg - everolimus
Israel -
hebreo -
Ministry of Health
אוורולימוס תרו 5 מג
taro international ltd, israel - everolimus - טבליה - everolimus 5 mg - everolimus
Israel -
hebreo -
Ministry of Health
אבטור 10
unipharm trading ltd, israel - everolimus - טבליה - everolimus 10 mg - everolimus
Israel -
hebreo -
Ministry of Health
אבטור 2.5
unipharm trading ltd, israel - everolimus - טבליה - everolimus 2.5 mg - everolimus
Israel -
hebreo -
Ministry of Health
אבטור 5
unipharm trading ltd, israel - everolimus - טבליה - everolimus 5 mg - everolimus
Israel -
hebreo -
Ministry of Health
ווטוביה 2 מג
novartis israel ltd - everolimus - טבליות ניתנות לפיזור - everolimus 2 mg - everolimus
Israel -
hebreo -
Ministry of Health
ווטוביה 3 מג
novartis israel ltd - everolimus - טבליות ניתנות לפיזור - everolimus 3 mg - everolimus
Israel -
hebreo -
Ministry of Health
סרטיקן ® 0.1 מ"ג טבליות מסיסות
novartis pharma services ag - everolimus 0.1 mg - tablets dispersible - everolimus - kidney and heart transplantationcertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.
Israel -
hebreo -
Ministry of Health
סרטיקן ® 0.25 מ"ג טבליות מסיסות
novartis pharma services ag - everolimus 0.25 mg - tablets dispersible - everolimus - kidney and heart transplantationcertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.